162 related articles for article (PubMed ID: 21923243)
41. Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme.
Chang SM; Lamborn KR; Malec M; Larson D; Wara W; Sneed P; Rabbitt J; Page M; Nicholas MK; Prados MD
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):353-7. PubMed ID: 15380566
[TBL] [Abstract][Full Text] [Related]
42. Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.
Son MJ; Kim JS; Kim MH; Song HS; Kim JT; Kim H; Shin T; Jeon HJ; Lee DS; Park SY; Kim YJ; Kim JH; Nam DH
Int J Oncol; 2006 Jan; 28(1):53-9. PubMed ID: 16327979
[TBL] [Abstract][Full Text] [Related]
43. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
44. Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy.
Storm PB; Moriarity JL; Tyler B; Burger PC; Brem H; Weingart J
J Neurooncol; 2002 Feb; 56(3):209-17. PubMed ID: 12061726
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of temozolomide treatment in patients with high-grade glioma.
Oshiro S; Tsugu H; Komatsu F; Ohmura T; Ohta M; Sakamoto S; Fukushima T; Inoue T
Anticancer Res; 2009 Mar; 29(3):911-7. PubMed ID: 19414327
[TBL] [Abstract][Full Text] [Related]
46. Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats.
DiMeco F; Li KW; Tyler BM; Wolf AS; Brem H; Olivi A
J Neurosurg; 2002 Nov; 97(5):1173-8. PubMed ID: 12450040
[TBL] [Abstract][Full Text] [Related]
47. Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma.
Sorensen DR; Read TA; Porwol T; Olsen BR; Timpl R; Sasaki T; Iversen PO; Benestad HB; Sim BK; Bjerkvig R
Neuro Oncol; 2002 Jan; 4(1):1-8. PubMed ID: 11772427
[TBL] [Abstract][Full Text] [Related]
48. Combination of endostatin and a protein kinase Calpha DNA enzyme improves the survival of rats with malignant glioma.
Sorensen DR; Leirdal M; Iversen PO; Sioud M
Neoplasia; 2002; 4(6):474-9. PubMed ID: 12407440
[TBL] [Abstract][Full Text] [Related]
49. TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors.
Liu Y; Wang Q; Kleinschmidt-DeMasters BK; Franzusoff A; Ng KY; Lillehei KO
J Neurooncol; 2007 Jan; 81(2):149-62. PubMed ID: 16941073
[TBL] [Abstract][Full Text] [Related]
50. [Intranasal administration of temozolomide for brain-targeting delivery: therapeutic effect on glioma in rats].
Li Y; Gao Y; Liu G; Zhou X; Wang Y; Wang Y; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):631-5. PubMed ID: 24849425
[TBL] [Abstract][Full Text] [Related]
51. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide.
Sheehan J; Cifarelli CP; Dassoulas K; Olson C; Rainey J; Han S
J Neurosurg; 2010 Aug; 113(2):234-9. PubMed ID: 20001586
[TBL] [Abstract][Full Text] [Related]
52. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.
Lesniak MS; Upadhyay U; Goodwin R; Tyler B; Brem H
Anticancer Res; 2005; 25(6B):3825-31. PubMed ID: 16312042
[TBL] [Abstract][Full Text] [Related]
53. Combination of photodynamic therapy and temozolomide on glioma in a rat C6 glioma model.
Zhang X; Guo M; Shen L; Hu S
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):603-12. PubMed ID: 25449156
[TBL] [Abstract][Full Text] [Related]
54. Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas.
Enríquez Pérez J; Kopecky J; Visse E; Darabi A; Siesjö P
BMC Cancer; 2020 Jan; 20(1):7. PubMed ID: 31900109
[TBL] [Abstract][Full Text] [Related]
55. Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.
Devineni D; Klein-Szanto A; Gallo JM
Cancer Res; 1996 May; 56(9):1983-7. PubMed ID: 8616836
[TBL] [Abstract][Full Text] [Related]
56. Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide.
Bartolomei M; Mazzetta C; Handkiewicz-Junak D; Bodei L; Rocca P; Grana C; Maira G; Sturiale C; Villa G; Paganelli G
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):220-8. PubMed ID: 15499296
[TBL] [Abstract][Full Text] [Related]
57. Epirubicin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers.
Recinos VR; Bekelis K; Ziegler SG; Vick D; Hertig S; Tyler BM; Li KW; Kosztowski T; Legnani FG; Brem H; Olivi A
J Neurooncol; 2010 Mar; 97(1):1-10. PubMed ID: 19693439
[TBL] [Abstract][Full Text] [Related]
58. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM
Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224
[TBL] [Abstract][Full Text] [Related]
59. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954
[TBL] [Abstract][Full Text] [Related]
60. Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group.
Margolin K; Atkins B; Thompson A; Ernstoff S; Weber J; Flaherty L; Clark I; Weiss G; Sosman J; II Smith W; Dutcher P; Gollob J; Longmate J; Johnson D
J Cancer Res Clin Oncol; 2002 Apr; 128(4):214-8. PubMed ID: 11935312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
